Synapse - Christopher Azzoli

Search Within

Christopher G Azzoli

Results (111)

2011 Focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non-small-cell lung cancer

Journal Article

Azzoli, C. G.; Temin, S.; Aliff, T.; Baker, S. Jr; Brahmer, J.; Johnson, D. H.; Laskin, J. L.; Masters, G.; Milton, D.; Nordquist, L.; more...
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

A phase II trial of salirasib in patients with lung adenocarcinomas with KRAS mutations

Journal Article

Riely, G. J.; Johnson, M. L.; Medina, C.; Rizvi, N. A.; Miller, V. A.; Kris, M. G.; Pietanza, M. C.; Azzoli, C. G.; Krug, L. M.; Pao, W.; more...
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Feasibility of longitudinal research with distressed family caregivers of lung cancer patients

Meeting Abstract

Mosher, C. E.; Ho, S.; Azzoli, C.; Lenderman, M.; Ostroff, J.
Annals of Behavioral Medicine (2011)

Fulltext@MSK | Save

A histological grading system has prognostic significance for patients with resected lung adenocarcinoma that received adjuvant chemotherapy

Meeting Abstract

D'Angelo, S. P.; Sima, C. S.; Azzoli, C. G.; Moreira, A. L.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene

Journal Article

Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib

Journal Article

Johnson, M. L.; Riely, G. J.; Rizvi, N. A.; Azzoli, C. G.; Kris, M. G.; Sima, C. S.; Ginsberg, M. S.; Pao, W.; Miller, V. A.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib

Journal Article

Janjigian, Y. Y.; Azzoli, C. G.; Krug, L. M.; Pereira, L. K.; Rizvi, N. A.; Pietanza, M. C.; Kris, M. G.; Ginsberg, M. S.; Pao, W.; Miller, V. A.; more...
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations

Journal Article

Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed

Journal Article

D'Angelo, S. P.; Kris, M. G.; Pietanza, M. C.; Rizvi, N. A.; Azzoli, C. G.
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

Journal Article

Brevet, M.; Johnson, M. L.; Azzoli, C. G.; Ladanyi, M.
Lung Cancer (2011)

Fulltext@MSK | Save